Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System | Sylvia E. Falcke et al. | ResearchPod

Transcript: Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System

Alex: Welcome to another episode of ResearchPod. Today we're looking at a study examining how radiation therapy affects different types of human immune cells.

Sam: So this paper is asking how radiation acts as a tool to either support or suppress our immune system during treatment?

Alex: Exactly. The puzzle is that while radiation is used to shrink tumors, we don't fully understand how it changes the way immune cells die — and that matters, because how a cell dies determines whether the body reacts with inflammation or not.

Sam: Right. If we don't know which cells die and how they die, we might be accidentally undermining the patient's ability to fight the cancer.

Alex: Precisely. Think of cell death like a traffic light system. Some cells die in a quiet, controlled way — they break down neatly from the inside and get cleared away without the body raising any alarms. Others die messily, like a burst pipe, spilling their contents everywhere.

Sam: And the body reacts very differently to those two outcomes?

Alex: It does. That quiet, controlled exit has a name: apoptosis. The cell essentially dismantles itself in an orderly way, and the immune system barely notices. But when a cell is hit hard — say, by a burst of high-energy radiation — it can rupture instead. That's called necrosis. The cell's contents spill out, and the immune system reads that as a distress signal. Inflammation follows.

Sam: So the same treatment — radiation — could be triggering very different responses depending on which cells it hits and how hard. How did the researchers actually track that?

Alex: They used a technique called flow cytometry. Picture a very precise sorting machine: cells are passed through a fluid stream one by one, and a laser scans each one. The researchers added special dyes — one called Propidium Iodide — that can only get inside a cell if its outer membrane has been broken. So if a cell lights up, you know it ruptured. If it stays dark, it died quietly.

Sam: It's like a leak detector for cells.

Alex: That's a good way to put it. And what they found was that different immune cell types respond to radiation in quite distinct ways.

Sam: What did the pattern look like?

Alex: Monocytes — a type of immune cell that acts as a first responder — were the most resistant. They held up relatively well under radiation. T cells, which are the immune system's targeted fighters, were more likely to die by rupture. And NK cells, another type of immune cell involved in hunting down abnormal cells, were more prone to that quiet, programmed death.

Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System

Sylvia E. Falcke, Paul F. Rühle, Lisa Deloch, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl

Nov 13, 2018·3:04·doi·Original Paper

RadiosensitivityHigh-Dose Radiotherapy (HDRT)Low-Dose Radiotherapy (LDRT)Cell Death MechanismsImmune ModulationLow-Dose Radiation Therapy (LDRT)

Listen

3 min

Briefing

Research Question

This study investigated how different doses of ionizing radiation—ranging from diagnostic levels to high-dose radiotherapy (HDRT)—impact the viability and specific modes of cell death (apoptosis, primary necrosis, and secondary necrosis) in human peripheral blood immune cells.

Approach

The researchers isolated T cells, B cells, NK cells, and monocytes from the peripheral blood of healthy donors. These cells were exposed to X-ray doses ranging from 0.01 Gy to 60 Gy. Using flow cytometry with Annexin V and propidium iodide (PI) staining, the team differentiated between viable, apoptotic, primary necrotic, and secondary necrotic cells at 24, 48, and 72 hours post-irradiation.

Main Findings

The study found that immune cells possess varying degrees of radiosensitivity. Monocytes were identified as the most radioresistant cell type. For lymphoid cells (T, B, and NK cells), radiation induced a dose-dependent increase in cell death. Notably, while apoptosis was observed, many cells rapidly progressed to secondary necrosis, particularly at higher doses. T cells were moderately radiosensitive and primarily underwent necrosis, while B and NK cells showed a higher propensity for apoptosis at lower doses. Very low doses (≤0.1 Gy) had minimal impact on cell death, whereas doses typical of low-dose radiotherapy (LDRT, 0.3–0.7 Gy) specifically affected the more sensitive NK and B cell populations.

Why It Matters

Understanding how radiotherapy affects immune cells is critical for optimizing cancer treatment protocols. Because immune cells are often present in the tumor microenvironment, their survival or death can significantly influence the efficacy of multimodal therapies, including the timing of immunotherapies. These findings provide a baseline for defining how different radiation regimens might modulate the immune system, potentially aiding in the design of more effective, personalized treatment schedules.

Key Terms and Definitions

Radiosensitivity — The relative susceptibility of cells to damage or death caused by exposure to ionizing radiation.
Primary Necrosis — A form of cell death characterized by cell swelling and loss of membrane integrity occurring directly due to severe damage, without the DNA fragmentation typical of apoptosis.
Secondary Necrosis — A process where cells that have initiated apoptosis lose their membrane integrity over time, often resulting in immune activation due to the release of intracellular contents.
Annexin V/PI Staining — A flow cytometry technique used to distinguish between living, apoptotic, and necrotic cells based on phosphatidylserine exposure and membrane permeability.
SubG1 DNA Content — A marker used in flow cytometry to identify cells with fragmented DNA, indicative of apoptosis or secondary necrosis.

Abstract

In cancer treatments, especially high-dose radiotherapy (HDRT) is applied. Patients suffering from chronic inflammatory diseases benefit from low-dose radiation therapy (LDRT), but exposure to very low radiation doses can still steadily increase for diagnostic purposes. Yet, little is known about how radiation impacts on forms of cell death in human immune cells. In this study, the radiosensitivity of human immune cells of the peripheral blood was examined in a dose range from 0.01 to 60 Gy with regard to induction of apoptosis, primary necrosis, and secondary necrosis. Results showed that immune cells differed in their radiosensitivity, with monocytes being the most radioresistant. T cells mainly died by necrosis and were moderately radiosensitive. This was followed by B and natural killer (NK) cells, which died mainly by apoptosis. X-radiation had no impact on cell death in immune cells at very low doses (≤0.1 Gy). Radiation doses of LDRT (0.3⁻0.7 Gy) impacted on the more radiosensitive NK and B cells, which might contribute to attenuation of inflammation. Even single doses applied during RT of tumors did not erase the immune cells completely. These in vitro studies can be considered as the basis to optimize individual radiation therapy schemes in multimodal settings and to define suited time points for further inclusion of immunotherapies.

Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System: Research Paper Podcast